How have NRXP and SEER total returns compared?

Over the past 5 years, NRXP delivered -49.61% and SEER delivered -40.97% annualized total return. Past performance doesn't predict future results.

NRx Pharmaceuticals, Inc. (NRXP) vs Seer, Inc. (SEER)

A side-by-side comparison of NRx Pharmaceuticals, Inc. and Seer, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NRXP

NRx Pharmaceuticals, Inc.

$127M

$2.94HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT

SEER

Seer, Inc.

$122M

$2.22HealthcareDelayed quote: Oct 6, 2026, 2:05 PM EDT

Total return — NRXP vs SEER

growth of $100 · dividends reinvested · last 6y

NRXP -97.4% (-45.5%/yr)SEER -95.9% (-41.2%/yr)SEER compounded faster over this window

NRXP SEER

NRXP vs SEER: by the numbers

•NRXP is the larger company ($127M vs $122M market cap).
•Both run net losses; SEER's is the smaller (-490.71% vs -691.81% net margin).

Metrics side by side

Valuation

Metric	NRXP	SEER
P/S ratio	37.50	8.79
P/B ratio	N/A	0.54

Profitability

Metric	NRXP	SEER
Gross margin	58.78%	46.31%
Operating margin	-1324.41%	-483.85%
Net margin	-691.81%	-490.71%
ROE	N/A	-30.12%
ROIC	N/A	-28.87%

Growth (annualized)

Metric	NRXP	SEER
Revenue CAGR (5Y)	N/A	51.57%
Total return CAGR (5Y)	-49.61%	-40.97%

Frequently asked

How have NRXP and SEER total returns compared?: Over the past 5 years, NRXP delivered -49.61% and SEER delivered -40.97% annualized total return. Past performance doesn't predict future results.

Go deeper

Full NRXP analysis Full SEER analysis Interactive comparison tool

Dig into the metrics

NRx Pharmaceuticals ROE Seer ROE NRx Pharmaceuticals operating margin Seer operating margin NRx Pharmaceuticals revenue growth Seer revenue growth NRx Pharmaceuticals free cash flow Seer free cash flow

NRx Pharmaceuticals & Seer appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.